Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases

Therapeutic Advances in Respiratory Disease
Pascale TomasiniFabrice Barlesi

Abstract

Molecular profiling of metastatic nonsquamous non-small cell lung cancer (NSCLC) is required to guide the treatment strategy. Anaplastic lymphoma kinase ( ALK) gene rearrangements are found in approximately 5% of lung adenocarcinomas and are associated with specific clinical features including a high risk of brain metastases. Crizotinib was the first ALK inhibitor developed and it demonstrated improved outcomes in patients with ALK-positive advanced NSCLC in comparison with chemotherapy. However, despite an initial response, all ALK-positive NSCLC patients develop acquired resistance to crizotinib. Because the most frequent mechanism of resistance is the development of a secondary ALK mutation, second (ceritinib, alectinib, brigatinib) and third-generation (lorlatinib) ALK inhibitors were developed. Alectinib is a second-generation ALK inhibitor and was shown to be effective for a broad spectrum of ALK rearrangements and ALK mutations. It was also shown to have high intracranial efficacy. In this article, we review clinical trial evidence of alectinib efficacy as well as publications reporting the experience of alectinib in daily practice, with a focus on brain metastases.

References

Feb 26, 2010·Annals of Surgical Oncology·Tsuyoshi TakahashiHiroshi Date
Feb 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alice T Shaw, Benjamin Solomon
Mar 23, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel B CostaKeith D Wilner
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Mar 29, 2014·The New England Journal of Medicine·Alice T ShawJeffrey A Engelman
Sep 11, 2014·Cancer Chemotherapy and Pharmacology·Tatsushi KodamaHiroshi Sakamoto
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators
Dec 20, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Justin F GainorAlice T Shaw
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Apr 18, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuChristopher Duma
Apr 23, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Giulio MetroStefania Gori
Jul 23, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Akihiro TamiyaShinji Atagi
Oct 5, 2015·The Lancet Oncology·Isabella ZhangBo Lu
Oct 7, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimberly L JohungJoseph N Contessa
Nov 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sai-Hong Ignatius OuDong-Wan Kim
Aug 9, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kentaro ItoNobuyuki Yamamoto
Nov 20, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirish M GadgeelSai-Hong Ignatius Ou
Feb 28, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Eiji IwamaIsamu Okamoto
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tomohide TamuraMakoto Nishio
May 6, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dong-Wan KimD Ross Camidge
Nov 25, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yoko NakanishiShu Hashimoto
Jan 27, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jessica J LinSai-Hong Ignatius Ou
Feb 8, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Anne McLeer-FlorinSylvie Lantuejoul
Mar 9, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David R SpigelGeorge Blumenschein
Mar 23, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Leora HornHeather A Wakelee
Apr 17, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C BurudpakdeeM Gubens
Apr 19, 2018·Medical Oncology·Biagio RicciutiRita Chiari
Apr 19, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S NovelloJ Wolf

❮ Previous
Next ❯

Citations

Aug 23, 2019·Current Opinion in Oncology·Nicola Rosenfelder, Michael Brada
Jun 2, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Ben E AndersonAnne C Silva-Benedict
Dec 25, 2019·Signal Transduction and Targeted Therapy·Min YuanQing Xu
Apr 5, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jyothi Dhuguru, Rachid Skouta
Jan 14, 2021·International Journal of Molecular Sciences·Agnieszka Rybarczyk-KasiuchniczKatarzyna Stencel
Mar 10, 2021·The Annals of Pharmacotherapy·Silvia Vázquez-GómezNatalia Fernández-Núñez
Dec 17, 2020·Signal Transduction and Targeted Therapy·Min YuanQing Xu
Apr 30, 2021·Cellular Oncology (Dordrecht)·Bikashita Kalita, Mohane Selvaraj Coumar
May 22, 2021·Pediatric Blood & Cancer·Shunsuke YamamotoShouichi Ohga
Jun 4, 2021·Experimental Biology and Medicine·Nathalie FuentesPatricia Silveyra
Jun 12, 2021·ChemMedChem·Chiara BorsariMatthias P Wymann

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
biopsies

Clinical Trials Mentioned

NCT02737501
NCT03052608
NCT02767804
NCT02013219
NCT02511184
NCT01998126
NCT02393625

Software Mentioned

PROFILE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.